Lagoda Investment Management LP Has Upped Its Tesla (TSLA) Holding by $6.03 Million; Haemonetics (HAE) Stock Value Rose While Beaconlight Capital Has Cut Position

April 20, 2018 - By Louis Casey

Tesla, Inc. (NASDAQ:TSLA) Logo

Ed Bosek decreased its stake in Haemonetics Corp (HAE) by 28.56% based on its latest 2017Q4 regulatory filing with the SEC. Beaconlight Capital Llc sold 36,900 shares as the company’s stock rose 23.57% while stock markets declined. The hedge fund run by Ed Bosek held 92,317 shares of the medical and dental instruments company at the end of 2017Q4, valued at $5.36M, down from 129,217 at the end of the previous reported quarter. Beaconlight Capital Llc who had been investing in Haemonetics Corp for a number of months, seems to be less bullish one the $4.07B market cap company. The stock increased 0.50% or $0.38 during the last trading session, reaching $76.12. About 159,769 shares traded. Haemonetics Corporation (NYSE:HAE) has risen 82.56% since April 20, 2017 and is uptrending. It has outperformed by 71.01% the S&P500.

Lagoda Investment Management Lp increased its stake in Tesla Inc (TSLA) by 99.39% based on its latest 2017Q4 regulatory filing with the SEC. Lagoda Investment Management Lp bought 19,380 shares as the company’s stock declined 14.15% with the market. The institutional investor held 38,878 shares of the capital goods company at the end of 2017Q4, valued at $12.11M, up from 19,498 at the end of the previous reported quarter. Lagoda Investment Management Lp who had been investing in Tesla Inc for a number of months, seems to be bullish on the $49.30B market cap company. The stock decreased 2.75% or $8.24 during the last trading session, reaching $291.84. About 4.14M shares traded. Tesla, Inc. (NASDAQ:TSLA) has risen 3.32% since April 20, 2017 and is uptrending. It has underperformed by 8.23% the S&P500.

Investors sentiment decreased to 1.11 in 2017 Q4. Its down 0.17, from 1.28 in 2017Q3. It worsened, as 20 investors sold HAE shares while 77 reduced holdings. 48 funds opened positions while 60 raised stakes. 50.89 million shares or 3.15% less from 52.55 million shares in 2017Q3 were reported. Amg Natl Trust Bancshares, a Colorado-based fund reported 19,558 shares. Van Berkom & Assocs owns 973,593 shares for 1.84% of their portfolio. The Illinois-based Citadel Ltd Com has invested 0% in Haemonetics Corporation (NYSE:HAE). 51,720 were reported by Los Angeles Capital Mgmt & Equity Rech Incorporated. Bogle Invest Management Ltd Partnership De stated it has 0.92% in Haemonetics Corporation (NYSE:HAE). Sei has invested 0% in Haemonetics Corporation (NYSE:HAE). Brinker Capital Inc invested in 0.01% or 5,687 shares. Ajo LP has invested 0.22% in Haemonetics Corporation (NYSE:HAE). Swiss Fincl Bank owns 89,600 shares for 0.01% of their portfolio. 353,459 are held by Capital Rech. Barrow Hanley Mewhinney & Strauss Ltd Liability Company has invested 0.01% in Haemonetics Corporation (NYSE:HAE). Segall Bryant And Hamill Llc accumulated 186,114 shares or 0.24% of the stock. Sg Americas Secs Limited Liability Company holds 6,086 shares. Systematic Financial Mngmt Limited Partnership holds 0.03% of its portfolio in Haemonetics Corporation (NYSE:HAE) for 26,295 shares. Alliancebernstein LP holds 0% or 80,606 shares.

Since January 2, 2018, it had 0 insider purchases, and 3 sales for $484,765 activity. Basil Michelle L sold $28,097 worth of Haemonetics Corporation (NYSE:HAE) on Tuesday, March 6. KROLL MARK W sold $448,434 worth of Haemonetics Corporation (NYSE:HAE) on Tuesday, January 2.

Among 10 analysts covering Haemonetics Corporation (NYSE:HAE), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Haemonetics Corporation had 28 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Thursday, December 21. Benchmark maintained the stock with “Hold” rating in Monday, November 7 report. The stock of Haemonetics Corporation (NYSE:HAE) earned “Hold” rating by Benchmark on Thursday, November 5. The stock of Haemonetics Corporation (NYSE:HAE) earned “Buy” rating by Jefferies on Tuesday, June 20. As per Friday, October 6, the company rating was maintained by Morgan Stanley. Craig Hallum maintained the stock with “Hold” rating in Wednesday, November 8 report. Barrington Research maintained the stock with “Outperform” rating in Tuesday, October 6 report. The firm has “Buy” rating by Morgan Stanley given on Wednesday, March 28. The stock has “Market Perform” rating by Raymond James on Tuesday, January 2. The stock has “Overweight” rating by Morgan Stanley on Tuesday, January 2.

Analysts await Haemonetics Corporation (NYSE:HAE) to report earnings on May, 8 before the open. They expect $0.43 EPS, up 10.26% or $0.04 from last year’s $0.39 per share. HAE’s profit will be $22.98 million for 44.26 P/E if the $0.43 EPS becomes a reality. After $0.62 actual EPS reported by Haemonetics Corporation for the previous quarter, Wall Street now forecasts -30.65% negative EPS growth.

Since October 24, 2017, it had 0 insider purchases, and 10 insider sales for $4.46 million activity. The insider Branderiz Eric sold 1,736 shares worth $589,355. The insider Musk Kimbal sold 4,065 shares worth $1.27 million.

Lagoda Investment Management Lp, which manages about $725.00M and $262.58M US Long portfolio, decreased its stake in Digimarc Corp New (NASDAQ:DMRC) by 16,437 shares to 670,859 shares, valued at $24.25 million in 2017Q4, according to the filing. It also reduced its holding in Intrexon Corp (NYSE:XON) by 97,322 shares in the quarter, leaving it with 82,685 shares, and cut its stake in Ptc Inc (NASDAQ:PTC).

Among 36 analysts covering Tesla Motors Inc (NASDAQ:TSLA), 12 have Buy rating, 9 Sell and 15 Hold. Therefore 33% are positive. Tesla Motors Inc had 140 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Tesla, Inc. (NASDAQ:TSLA) earned “Underweight” rating by Barclays Capital on Friday, October 9. The stock has “Sell” rating by CFRA on Wednesday, November 1. Goldman Sachs upgraded Tesla, Inc. (NASDAQ:TSLA) on Wednesday, May 18 to “Buy” rating. On Thursday, November 2 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm has “Sell” rating given on Monday, March 19 by Jefferies. Morgan Stanley maintained the shares of TSLA in report on Tuesday, September 22 with “Overweight” rating. Robert W. Baird maintained the shares of TSLA in report on Thursday, January 4 with “Buy” rating. The firm earned “Sector Perform” rating on Thursday, October 27 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Monday, January 22 with “Hold”. As per Monday, October 30, the company rating was maintained by UBS.

Tesla, Inc. (NASDAQ:TSLA) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>